Tags

Type your tag names separated by a space and hit enter

Vaccination of travelers: how far have we come and where are we going?
Expert Rev Vaccines. 2011 Nov; 10(11):1609-20.ER

Abstract

Vaccine recommendations are a prominent part of health preparations before international travel. We review progress made in the past decade regarding vaccines used primarily by persons traveling from high-income countries to low- and middle-income countries. The combined hepatitis A-B vaccine, the recently licensed Vero cell-derived Japanese encephalitis vaccine and conjugated quadrivalent meningococcal vaccines are discussed. This article provides updates on yellow fever vaccine-associated visceral and neurologic adverse events, indications for influenza vaccine in travelers, the rapid immunization schedule for tick-borne encephalitis vaccine, schedules for postexposure rabies prophylaxis, and new insights about oral cholera vaccines following the outbreak in Haiti. The future should bring vaccines for serogroup B Neiserria meningitidis, dengue and malaria, as well as an inactivated yellow fever vaccine.

Links

Publisher Full Text
Aggregator Full Text

Authors+Show Affiliations

Chen LH
Mount Auburn Hospital, Cambridge, MA, USA. lchen@hms.harvard.edu
Hill DR
No affiliation info available
Wilder-Smith A
No affiliation info available

MeSH

Bacterial InfectionsBacterial VaccinesHistory, 21st CenturyHumansPost-Exposure ProphylaxisTravelTravel MedicineVaccinationViral VaccinesVirus Diseases

Pub Type(s)

Historical Article
Journal Article
Review

Language

eng

PubMed ID

22043959

Citation

Chen, Lin H., et al. "Vaccination of Travelers: How Far Have We Come and Where Are We Going?" Expert Review of Vaccines, vol. 10, no. 11, 2011, pp. 1609-20.
Chen LH, Hill DR, Wilder-Smith A. Vaccination of travelers: how far have we come and where are we going? Expert Rev Vaccines. 2011;10(11):1609-20.
Chen, L. H., Hill, D. R., & Wilder-Smith, A. (2011). Vaccination of travelers: how far have we come and where are we going? Expert Review of Vaccines, 10(11), 1609-20. https://doi.org/10.1586/erv.11.138
Chen LH, Hill DR, Wilder-Smith A. Vaccination of Travelers: How Far Have We Come and Where Are We Going. Expert Rev Vaccines. 2011;10(11):1609-20. PubMed PMID: 22043959.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Vaccination of travelers: how far have we come and where are we going? AU - Chen,Lin H, AU - Hill,David R, AU - Wilder-Smith,Annelies, PY - 2011/11/3/entrez PY - 2011/11/3/pubmed PY - 2012/2/22/medline SP - 1609 EP - 20 JF - Expert review of vaccines JO - Expert Rev Vaccines VL - 10 IS - 11 N2 - Vaccine recommendations are a prominent part of health preparations before international travel. We review progress made in the past decade regarding vaccines used primarily by persons traveling from high-income countries to low- and middle-income countries. The combined hepatitis A-B vaccine, the recently licensed Vero cell-derived Japanese encephalitis vaccine and conjugated quadrivalent meningococcal vaccines are discussed. This article provides updates on yellow fever vaccine-associated visceral and neurologic adverse events, indications for influenza vaccine in travelers, the rapid immunization schedule for tick-borne encephalitis vaccine, schedules for postexposure rabies prophylaxis, and new insights about oral cholera vaccines following the outbreak in Haiti. The future should bring vaccines for serogroup B Neiserria meningitidis, dengue and malaria, as well as an inactivated yellow fever vaccine. SN - 1744-8395 UR - https://www.unboundmedicine.com/medline/citation/22043959/Vaccination_of_travelers:_how_far_have_we_come_and_where_are_we_going L2 - https://www.tandfonline.com/doi/full/10.1586/erv.11.138 DB - PRIME DP - Unbound Medicine ER -